NCT02874131

Brief Summary

This study is a randomized controlled trial comparing an integrated treatment, Behavioral Activation + Cognitive Processing Therapy (BA + CPT), to CPT alone among active-duty service members with posttraumatic stress disorder (PTSD) and comorbid major depressive disorder (MDD). Participants will complete assessor-administered and self-report measures at pre- and post-treatment assessments, as well as a 3-month follow-up. Additionally, participants will complete self-report measures of PTSD and MDD symptoms at each therapy session.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 22, 2016

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2022

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

6.4 years

First QC Date

August 2, 2016

Last Update Submit

November 13, 2024

Conditions

Keywords

Posttraumatic Stress DisorderMajor Depressive DisorderBehavioral ActivationCognitive Processing TherapyComorbidityMilitary

Outcome Measures

Primary Outcomes (1)

  • Montgomery-Asberg Depression Rating Scale (MADRS)

    Assessor-administered measure of depression symptoms

    Prior to beginning treatment through three months following treatment completion (approximately 10 months)

Secondary Outcomes (2)

  • Clinician-Administered PTSD Scale for the DSM-5 (CAPS-5)

    Prior to beginning treatment through three months following treatment completion (approximately 10 months)

  • Patient Health Questionnaire (PHQ-9)

    Prior to beginning treatment through three months following treatment completion (approximately 10 months)

Study Arms (2)

Behavioral Activation + CPT

EXPERIMENTAL

Behavioral Activation, an evidence-based treatment for depression, is combined with Cognitive Processing Therapy (CPT), an evidence-based treatment for PTSD, to address symptoms of PTSD and comorbid MDD.

Behavioral: Behavioral ActivationBehavioral: Cognitive Processing Therapy

Cognitive Processing Therapy

ACTIVE COMPARATOR

CPT is an evidence-based treatment for PTSD that has also been shown to reduce depression symptoms.

Behavioral: Cognitive Processing Therapy

Interventions

Behavioral activation

Also known as: BA
Behavioral Activation + CPT

Cognitive processing therapy

Also known as: CPT
Behavioral Activation + CPTCognitive Processing Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active-duty service member seeking mental health treatment at Naval Medical Center San Diego (NMCSD), branch clinics, or Naval Hospital Camp Pendleton (NHCP)
  • Meet current diagnostic criteria for PTSD based on the DSM-5 as a consequence of any index traumatic event (e.g., combat, military sexual trauma, child abuse, accidents, etc.)
  • Meet current diagnostic criteria for MDD based on DSM-5 criteria.

You may not qualify if:

  • Unmanaged psychosis or manic episode in the past year
  • Substance use disorder warranting primary substance use treatment or detoxification
  • Participation in concurrent psychotherapies directly targeting PTSD
  • Participation in concurrent psychotherapies directly targeting depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Naval Medical Center San Diego

San Diego, California, 92134, United States

Location

Related Publications (5)

  • Walter KH, Glassman LH, Michael Hunt W, Otis NP, Thomsen CJ. Evaluation of an integrated treatment for active duty service members with comorbid posttraumatic stress disorder and major depressive disorder: Study protocol for a randomized controlled trial. Contemp Clin Trials. 2018 Jan;64:152-160. doi: 10.1016/j.cct.2017.10.010. Epub 2017 Nov 7.

    PMID: 29107036BACKGROUND
  • Walter KH, Hunt WM, Otis NP, Kline AC, Miggantz EL, Thomsen CJ, Glassman LH. Comparison of behavioral activation-enhanced cognitive processing therapy and cognitive processing therapy among U.S. service members: A randomized clinical trial. Psychiatry Res. 2023 Aug;326:115330. doi: 10.1016/j.psychres.2023.115330. Epub 2023 Jul 4.

  • Kline AC, Otis NP, Norman SB, Hunt WM, Walter KH. Dropout in a clinical trial for comorbid PTSD and MDD among US service members: Are pretreatment characteristics predictive? Psychother Res. 2025 Apr;35(4):614-626. doi: 10.1080/10503307.2024.2325519. Epub 2024 Mar 18.

  • Glassman LH, Otis NP, Kline AC, Hunt WM, Walter KH. Sex differences in treatment outcomes among U.S. service members with comorbid PTSD and MDD. BMC Psychol. 2026 Jan 31. doi: 10.1186/s40359-025-03878-4. Online ahead of print.

  • Otis NP, Kline AC, Glassman LH, Michael Hunt W, Walter KH. Sudden gains in cognitive processing therapy with and without behavioral activation among service members with comorbid PTSD and MDD. Behav Res Ther. 2025 Jul;190:104753. doi: 10.1016/j.brat.2025.104753. Epub 2025 Apr 22.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDepressive Disorder, Major

Interventions

2-cyclohexylidenhydrazo-4-phenyl-thiazole

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersDepressive DisorderMood Disorders

Study Officials

  • William M. Hunt, Ph.D.

    United States Naval Medical Center, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Psychologist

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 22, 2016

Study Start

October 20, 2015

Primary Completion

March 18, 2022

Study Completion

March 18, 2022

Last Updated

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Data will be available only in aggregate

Locations